External validation of the FIRST trial’s simplified frailty score in a population-based cohort

Abstract not available.

Information

Citation

Mian HS, Giri S, Wildes TM, Balitsky AK, McCurdy A, Pond GR, Sivapathasundaram B, Seow H. Leukemia. 2021; 35(6):1823-7. Epub 2021 Apr 10.

View Source

Discover More

Journal Article

02/02/2026

Incidence of psychotic disorders by birth cohort: a population-based cohort study in Ontario, Canada

Myran DT, Gibb M, Pugliese M, Fiedorowicz JG, Anderson KK, Ramsay T, Jalal H, Kurdyak P, Solmi M. CMAJ. 2026; 198(4): E118-E127.

Journal Article

30/01/2026

Development and validation of the Predicting Risk of Ischemic Stroke in Malignancy Estimation tool

Lun R, Leentjens J, Cerasuolo JO, Kirkwood D, Kapral MK, Carrier M, Siegal D, Sutradhar R. J Am Heart Assoc. 2026; e045631. Epub 2026 Jan 30.

Journal Article

28/01/2026

Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients

Acuna SA, Zhao X, Jones-Carr M, Smith G, Naylor K, Hasjim BJ, Chen S, Chan AW, Baxter N, Kim SJ, Bhat M. Int J Cancer. 2026; Jan 28 [Epub ahead of print].

See All

External validation of the FIRST trial’s simplified frailty score in a population-based cohort

Information

Citation

Contributing ICES Scientists

Research Programs

Associated Sites

Discover More

Incidence of psychotic disorders by birth cohort: a population-based cohort study in Ontario, Canada

Development and validation of the Predicting Risk of Ischemic Stroke in Malignancy Estimation tool

Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients